NO and transcriptional regulation: From signaling to death

Toxicology

Volumn 208, Issue 2, 2005, Pages 223-233

  Zhou, Jie ^a   Brüne, Bernhard ^a  

^a Rheinland Pfälzische Technische Universität Kaiserslautern Landau   (Germany)

Author keywords

Apoptosis; HIF 1 ; Hypoxia; Mdm2; p53; Proteasome; pVHL; Ubiquitination

Indexed keywords

GENE PRODUCT; HYPOXIA INDUCIBLE FACTOR 1ALPHA; NITRIC OXIDE; OXYGEN; PROTEIN P53; REACTIVE NITROGEN SPECIES;

APOPTOSIS; CELL DEATH; CELL PROLIFERATION; CELL TYPE; CHEMICAL REACTION; DNA BINDING; DNA DAMAGE; IRON METABOLISM; MITOCHONDRIAL RESPIRATION; NITROSYLATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN TARGETING; REVIEW; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; UBIQUITINATION;

EUKARYOTA;

EID: 13244255346     PISSN: 0300483X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tox.2004.11.021     Document Type: Article

References (90)

1. W.K. Alderton, C.E. Cooper, and R.G. Knowles Nitric oxide synthases: structure, function and inhibition Biochem. J. 357 2001 593 615
2. 2+ of extradiol dioxygenases J. Biol. Chem. 260 1985 14035 14044
3. C. Bogdan Nitric oxide and the regulation of gene expression Trends Cell Biol. 11 2001 66 75
4. S.D. Boyd, K.Y. Tsai, and T. Jacks An intact HDM2 RING-finger domain is required for nuclear exclusion of p53 Nat. Cell Biol. 2 2000 563 568
5. R.K. Bruick, and S.L. McKnight A conserved family of prolyl-4- hydroxylases that modify HIF Science 294 2001 1337 1340
6. B. Brüne, A. von Knethen, and K.B. Sandau Transcription factors p53 and HIF-1alpha as targets of nitric oxide Cell. Signal. 13 2001 525 533
7. B. Brüne Nitric oxide: NO apoptosis or turning it ON? Cell Death Differ. 10 2003 864 869
8. B. Brüne, and N. Schneiderhan Nitric oxide evoked p53-accumulation and apoptosis Toxicol. Lett. 139 2003 119 123
9. B. Brüne, and J. Zhou The role of nitric oxide (NO) in stability regulation of hypoxia inducible factor-1alpha (HIF-1alpha) Curr. Med. Chem. 10 2003 845 855
10. A.R. Butler, F.W. Flitney, and D.L. Williams NO, nitrosonium ions, nitroxide ions, nitrosothiols and iron-nitrosyls in biology: a chemist's perspective Trends Pharmacol. Sci. 16 1995 18 22
11. J. Chen, X. Wu, J. Lin, and A.J. Levine Mdm-2 inhibits the G1 arrest and apoptosis functions of the p53 tumor suppressor protein Mol. Cell Biol. 16 1996 2445 2452
12. Y.S. Chun, E. Choi, T.Y. Kim, M.S. Kim, and J.W. Park A dominant-negative isoform lacking exons 11 and 12 of the human hypoxia-inducible factor-1alpha gene Biochem. J. 362 2002 71 79
13. D.W. Davis, D.A. Weidner, A. Holian, and D.J. McConkey Nitric oxide-dependent activation of p53 suppresses bleomycin-induced apoptosis in the lung J. Exp. Med. 192 2000 857 869
14. N. Dumaz, and D.W. Meek Serine15 phosphorylation stimulates p53 transactivation but does not directly influence interaction with HDM2 EMBO J. 18 1999 7002 7010
15. A.C. Epstein, J.M. Gleadle, L.A. McNeill, K.S. Hewitson, J. O'Rourke, D.R. Mole, M. Mukherji, E. Metzen, M.I. Wilson, A. Dhanda, Y.M. Tian, N. Masson, D.L. Hamilton, P. Jaakkola, R. Barstead, J. Hodgkin, P.H. Maxwell, C.W. Pugh, C.J. Schofield, and P.J. Ratcliffe C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation Cell 107 2001 43 54
16. S.Y. Fuchs, V. Adler, T. Buschmann, X. Wu, and Z. Ronai Mdm2 association with p53 targets its ubiquitination Oncogene 17 1998 2543 2547
17. M. Fukuda, S. Asano, T. Nakamura, M. Adachi, M. Yoshida, M. Yanagida, and E. Nishida CRM1 is responsible for intracellular transport mediated by the nuclear export signal Nature 390 1997 308 311
18. R.F. Furchgott, and J.V. Zawadzki The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine Nature 288 1980 373 376
19. R.K. Geyer, Z.K. Yu, and C.G. Maki The MDM2 RING-finger domain is required to promote p53 nuclear export Nat. Cell Biol. 2 2000 569 573
20. S.A. Gordon, W. Abou-Jaoude, R.A. Hoffman, S.A. McCarthy, Y.M. Kim, X. Zhou, X.R. Zhang, R.L. Simmons, Y. Chen, L. Schall, and H.R. Ford Nitric oxide induces murine thymocyte apoptosis by oxidative injury and a p53-dependent mechanism J. Leukoc. Biol. 70 2001 87 95
21. V. Gottifredi, and C. Prives Molecular biology. Getting p53 out of the nucleus Science 292 2001 1851 1852
22. M.B. Grisham, D. Jourd'Heuil, and D.A. Wink Nitric oxide. I. Physiological chemistry of nitric oxide and its metabolites: implications in inflammation Am. J. Physiol. 276 1999 G315 G321
23. Y. Haupt, R. Maya, A. Kazaz, and M. Oren Mdm2 promotes the rapid degradation of p53 Nature 387 1997 296 299
24. Y. Haupt, A.I. Robles, C. Prives, and V. Rotter Deconstruction of p53 functions and regulation Oncogene 21 2002 8223 8231
25. E.L. Hegg, and L. Que Jr. The 2-His-1-carboxylate facial triad-an emerging structural motif in mononuclear non-heme iron(II) enzymes Eur. J. Biochem. 250 1997 625 629
26. J. Hemish, N. Nakaya, V. Mittal, and G. Enikolopov Nitric oxide activates diverse signaling pathways to regulate gene expression J. Biol. Chem. 278 2003 42321 42329
27. L.J. Hofseth, S. Saito, S.P. Hussain, M.G. Espey, K.M. Miranda, Y. Araki, C. Jhappan, Y. Higashimoto, P. He, S.P. Linke, M.M. Quezado, I. Zurer, V. Rotter, D.A. Wink, E. Appella, and C.C. Harris Nitric oxide-induced cellular stress and p53 activation in chronic inflammation Proc. Natl. Acad. Sci. U.S.A. 100 2003 143 148
28. R. Honda, H. Tanaka, and H. Yasuda Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53 FEBS Lett. 420 1997 25 27
29. L.E. Huang, W.G. Willmore, J. Gu, M.A. Goldberg, and H.F. Bunn Inhibition of hypoxia-inducible factor 1 activation by carbon monoxide and nitric oxide J. Biol. Chem. 274 1999 9038 9044
30. L.E. Huang, and H.F. Bunn Hypoxia-inducible factor and its biomedical relevance J. Biol. Chem. 278 2003 19575 19578
31. A. Ishida, T. Sasaguri, Y. Miwa, C. Kosaka, Y. Taba, and T. Abumiya Tumor suppressor p53 but not cGMP mediates NO-induced expression of p21 (Waf1/Cip1/Sdi1) in vascular smooth muscle cells Mol. Pharmacol. 56 1999 938 946
32. 2 sensing Science 292 2001 464 468
33. 2-regulated prolyl hydroxylation Science 292 2001 468 472
34. W.G. Kaelin Jr. How oxygen makes its presence felt Genes Dev. 16 2002 1441 1445
35. P.J. Kallio, W.J. Wilson, S. O'Brien, Y. Makino, and L. Poellinger Regulation of the hypoxia-inducible transcription factor 1alpha by the ubiquitin-proteasome pathway J. Biol. Chem. 274 1999 6519 6525
36. K. Kasuno, S. Takabuchi, K. Fukuda, S. Kizaka-Kondoh, J. Yodoi, T. Adachi, G.L. Semenza, and K. Hirota Nitric oxide induces hypoxia-inducible factor 1 activation that is dependent on MAP kinase and phosphatidylinositol 3-kinase signaling J. Biol. Chem. 279 2004 2550 2558
37. H. Kimura, A. Weisz, Y. Kurashima, K. Hashimoto, T. Ogura, F. D'Acquisto, R. Addeo, M. Makuuchi, and H. Esumi Hypoxia response element of the human vascular endothelial growth factor gene mediates transcriptional regulation by nitric oxide: control of hypoxia-inducible factor-1 activity by nitric oxide Blood 95 2000 189 197
38. H. Kimura, A. Weisz, T. Ogura, Y. Hitomi, Y. Kurashima, K. Hashimoto, F. D'Acquisto, M. Makuuchi, and H. Esumi Identification of hypoxia-inducible factor 1 ancillary sequence and its function in vascular endothelial growth factor gene induction by hypoxia and nitric oxide J. Biol. Chem. 276 2001 2292 2298
39. W.H. Koppenol NO nomenclature? Nitric Oxide 6 2002 96 98
40. M.H. Kubbutat, S.N. Jones, and K.H. Vousden Regulation of p53 stability by Mdm2 Nature 387 1997 299 303
41. M.H. Kubbutat, R.L. Ludwig, M. Ashcroft, and K.H. Vousden Regulation of Mdm2-directed degradation by the C terminus of p53 Mol. Cell Biol. 18 1998 5690 5698
42. N. Kudo, B. Wolff, T. Sekimoto, E.P. Schreiner, Y. Yoneda, M. Yanagida, S. Horinouchi, and M. Yoshida Leptomycin B inhibition of signal-mediated nuclear export by direct binding to CRM1 Exp. Cell Res. 242 1998 540 547
43. D. Lando, D.J. Peet, D.A. Whelan, J.J. Gorman, and M.L. Whitelaw Asparagine hydroxylation of the HIF transactivation domain a hypoxic switch Science 295 2002 858 861
44. C.Q. Li, L.J. Trudel, and G.N. Wogan Nitric oxide-induced genotoxicity, mitochondrial damage, and apoptosis in human lymphoblastoid cells expressing wild-type and mutant p53 Proc. Natl. Acad. Sci. U.S.A. 99 2002 10364 10369
45. S.H. Liang, and M.F. Clarke Regulation of p53 localization Eur. J. Biochem. 268 2001 2779 2783
46. Y. Liu, H. Christou, T. Morita, E. Laughner, G.L. Semenza, and S. Kourembanas Carbon monoxide and nitric oxide suppress the hypoxic induction of vascular endothelial growth factor gene via the 5′ enhancer J. Biol. Chem. 273 1998 15257 15262
47. C.G. Maki, J.M. Huibregtse, and P.M. Howley In vivo ubiquitination and proteasome-mediated degradation of p53 Cancer Res. 56 1996 2649 2654
48. C.G. Maki Oligomerization is required for p53 to be efficiently ubiquitinated by MDM2 J. Biol. Chem. 274 1999 16531 16535
49. H.E. Marshall, K. Merchant, and J.S. Stamler Nitrosation and oxidation in the regulation of gene expression FASEB J. 14 2000 1889 1900
50. J. Mateo, M. Garcia-Lecea, S. Cadenas, C. Hernandez, and S. Moncada Regulation of hypoxia-inducible factor-1alpha by nitric oxide through mitochondria-dependent and -independent pathways Biochem. J. 376 2003 537 544
51. M. Matsuoka, and H. Igisu Cadmium induces phosphorylation of p53 at serine 15 in MCF-7 cells Biochem. Biophys. Res. Commun. 282 2001 1120 1125
52. P.H. Maxwell, M.S. Wiesener, G.-W. Chang, S.C. Clifford, E.C. Vaux, M.E. Cockman, C.C. Wykoff, C.W. Pugh, E.R. Maher, and P.J. Ratcliffe The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis Nature Lett. 399 1999 271 275
53. P.H. Maxwell, C.W. Pugh, and P.J. Ratcliffe The pVHL-HIF-1 system. A key mediator of oxygen homeostasis Adv. Exp. Med. Biol. 502 2001 365 376
54. U.K. Messmer, M. Ankarcrona, P. Nicotera, and B. Brune p53 Expression in nitric oxide-induced apoptosis FEBS Lett. 355 1994 23 26
55. E. Metzen, J. Zhou, W. Jelkmann, J. Fandrey, and B. Brüne Nitric oxide impairs normoxic degradation of HIF-1alpha by inhibition of prolyl hydroxylases Mol. Biol. Cell 14 2003 3470 3481
56. S. Moncada, and E.A. Higgs Molecular mechanisms and therapeutic strategies related to nitric oxide FASEB J. 9 1995 1319 1330
57. N. Nakaya, S.W. Lowe, Y. Taya, A. Chenchik, and G. Enikolopov Specific pattern of p53 phosphorylation during nitric oxide-induced cell cycle arrest Oncogene 19 2000 6369 6375
58. C. Nathan Nitric oxide as a secretory product of mammalian cells FASEB J. 6 1992 3051 3064
59. C. Nathan, and M.U. Shiloh Reactive oxygen and nitrogen intermediates in the relationship between mammalian hosts and microbial pathogens Proc. Natl. Acad. Sci. U.S.A. 97 2000 8841 8848
60. F. Oehme, P. Ellinghaus, P. Kolkhof, T.J. Smith, S. Ramakrishnan, J. Hutter, M. Schramm, and I. Flamme Overexpression of PH-4, a novel putative proline 4-hydroxylase, modulates activity of hypoxia-inducible transcription factors Biochem. Biophys. Res. Commun. 296 2002 343 349
61. J.D. Oliner, K.W. Kinzler, P.S. Meltzer, D.L. George, and B. Vogelstein Amplification of a gene encoding a p53-associated protein in human sarcomas Nature 358 1992 80 83
62. M. Oren Decision making by p53: life, death and cancer Cell Death Differ. 10 2003 431 442
63. L.A. Palmer, B. Gaston, and R.A. Johns Normoxic stabilization of hypoxia-inducible factor-1 expression and activity: redox-dependent effect of nitrogen oxides Mol. Pharmacol. 58 2000 1197 1203
64. C.W. Pugh, and P.J. Ratcliffe The von Hippel-Lindau tumor suppressor, hypoxia-inducible factor-1 (HIF-1) degradation, and cancer pathogenesis Semin. Cancer Biol. 13 2003 83 89
65. P.L. Roach, I.J. Clifton, V. Fulop, K. Harlos, G.J. Barton, J. Hajdu, I. Andersson, C.J. Schofield, and J.E. Baldwin Crystal structure of isopenicillin N synthase is the first from a new structural family of enzymes Nature 375 1995 700 704
66. C.P. Rubbi, and J. Milner Disruption of the nucleolus mediates stabilization of p53 in response to DNA damage and other stresses EMBO J. 22 2003 6068 6077
67. S. Salceda, and J. Caro Hypoxia-inducible factor 1alpha (HIF-1alpha) protein is rapidly degraded by the ubiquitin-proteasome system under normoxic conditions J. Biol. Chem. 272 1997 22642 22647
68. K.B. Sandau, J. Fandrey, and B. Brüne Accumulation of HIF-1alpha under the influence of nitric oxide Blood 97 2001 1009 1015
69. K.B. Sandau, J. Zhou, T. Kietzmann, and B. Brüne Regulation of the hypoxia-inducible factor 1alpha by the inflammatory mediators nitric oxide and tumor necrosis factor-alpha in contrast to desferroxamine and phenylarsine oxide J. Biol. Chem. 276 2001 39805 39811
70. H.H. Schmidt, and U. Walter NO at work Cell 78 1994 919 925
71. N. Schneiderhan, A. Budde, Y. Zhang, and B. Brüne Nitric oxide induces phosphorylation of p53 and impairs nuclear export Oncogene 22 2003 2857 2868
72. G.L. Semenza, and G.L. Wang A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation Mol. Cell Biol. 12 1992 5447 5454
73. G.L. Semenza HIF-1 and human disease: one highly involved factor Genes Dev. 14 2000 1983 1991
74. G.L. Semenza HIF-1 and tumor progression: pathophysiology and therapeutics Trends Mol. Med. 8 2002 62 67
75. E.A. Sheta, H. Trout, J.J. Gildea, M.A. Harding, and D. Theodorescu Cell density mediated pericellular hypoxia leads to induction of HIF-1alpha via nitric oxide and Ras/MAP kinase mediated signaling pathways Oncogene 20 2001 7624 7634
76. S.Y. Shieh, M. Ikeda, Y. Taya, and C. Prives DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2 Cell 91 1997 325 334
77. J.D. Siliciano, C.E. Canman, Y. Taya, K. Sakaguchi, E. Appella, and M.B. Kastan DNA damage induces phosphorylation of the amino terminus of p53 Genes Dev. 11 1997 3471 3481
78. K. Sogawa, K. Numayama-Tsuruta, M. Ema, M. Abe, H. Abe, and Y. Fujii-Kuriyama Inhibition of hypoxia-inducible factor 1 activity by nitric oxide donors in hypoxia Proc. Natl. Acad. Sci. U.S.A. 95 1998 7368 7373
79. J.S. Stamler Redox signaling: nitrosylation and related target interactions of nitric oxide Cell 78 1994 931 936
80. V.V. Sumbayev, A. Budde, J. Zhou, and B. Brüne HIF-1alpha protein as a target for S-nitrosation FEBS Lett. 535 2003 106 112
81. B. Tian, J. Liu, P.B. Bitterman, and R.J. Bache Mechanisms of cytokine induced NO-mediated cardiac fibroblast apoptosis Am. J. Physiol. Heart Circ. Physiol. 283 2002 H1958 H1967
82. K.H. Vousden Activation of the p53 tumor suppressor protein Biochim. Biophys. Acta 1602 2002 47 59
83. G.L. Wang, and G.L. Semenza Purification and characterization of hypoxia-inducible factor 1 J. Biol. Chem. 270 1995 1230 1237
84. X. Wang, D. Michael, G. de Murcia, and M. Oren p53 Activation by nitric oxide involves down-regulation of Mdm2 J. Biol. Chem. 277 2002 15697 15702
85. X. Wang, A. Zalcenstein, and M. Oren Nitric oxide promotes p53 nuclear retention and sensitizes neuroblastoma cells to apoptosis by ionizing radiation Cell Death Differ. 10 2003 468 476
86. 2-regulated gene expression FASEB J. 16 2002 1151 1162
87. M. Xiong, G. Elson, D. Legarda, and S.J. Leibovich Production of vascular endothelial growth factor by murine macrophages: regulation by hypoxia, lactate, and the inducible nitric oxide synthase pathway Am. J. Pathol. 153 1998 587 598
88. Y. Zhang, and Y. Xiong A p53 amino-terminal nuclear export signal inhibited by DNA damage-induced phosphorylation Science 292 2001 1910 1915
89. Y. Zhang, and Y. Xiong Control of p53 ubiquitination and nuclear export by MDM2 and ARF Cell Growth Differ. 12 2001 175 186
90. J. Zhou, J. Fandrey, J. Schumann, G. Tiegs, and B. Brüne NO and TNF-alpha released from activated macrophages stabilize HIF-1alpha in resting tubular LLC-PK1 cells Am. J. Physiol. Cell Physiol. 284 2003 C439 C446